These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18245901)

  • 1. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.
    Deng G; Huang XJ; Luo HW; Huang FZ; Liu XY; Wang YH
    World J Gastroenterol; 2013; 19(43):7778-87. PubMed ID: 24431897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.
    Morales-Ruiz M; Cejudo-Martín P; Fernández-Varo G; Tugues S; Ros J; Angeli P; Rivera F; Arroyo V; Rodés J; Sessa WC; Jiménez W
    Gastroenterology; 2003 Aug; 125(2):522-31. PubMed ID: 12891555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.
    Fernández-Varo G; Melgar-Lesmes P; Casals G; Pauta M; Arroyo V; Morales-Ruiz M; Ros J; Jiménez W
    J Hepatol; 2010 Dec; 53(6):1041-8. PubMed ID: 20800923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
    Garcia-Bañuelos J; Siller-Lopez F; Miranda A; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
    Gene Ther; 2002 Jan; 9(2):127-34. PubMed ID: 11857071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.
    Yamaguchi S; Kawanaka H; Yoshida D; Maehara Y; Hashizume M
    Life Sci; 2007 May; 80(22):2036-44. PubMed ID: 17481668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers.
    Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Jin W; Kwon YH; Shin MK; Yoo TM; Kang JH; Park CS
    Life Sci; 2009 Aug; 85(7-8):281-90. PubMed ID: 19527736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
    Liu CH; Huang XT; Li YY; Zheng X; Li N; Mi SQ; Wang NS
    Zhong Yao Cai; 2012 Jun; 35(6):930-5. PubMed ID: 23236829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats].
    Qiu JF; Wu ZY; Zhang ZQ; Luo HF
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):428-31. PubMed ID: 15144673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
    J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.
    Yu Q; Shao R; Qian HS; George SE; Rockey DC
    J Clin Invest; 2000 Mar; 105(6):741-8. PubMed ID: 10727442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
    Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The roles of caveolin-1 and endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis].
    Xu B; Zhu GH; Weng JF; Cai WS; Xia JT; Li SH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):184-7. PubMed ID: 18364076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.